Literature DB >> 6658950

Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study.

R G Hart, B M Coull, D Hart.   

Abstract

Nonvalvular atrial fibrillation (NVAF) can be a source of cardiogenic brain embolism. We retrospectively reviewed the clinical features of 56 patients with acute brain infarction and NVAF. Based on clinical criteria, 35 infarcts (63%) were classified as probably embolic, 13 infarcts (23%) as probably nonembolic and 8 infarcts (14%) as of indeterminate pathogenesis. Among the 35 patients with presumed embolic infarcts, 12 patients were immediately anticoagulated without hemorrhagic complications. Of 23 patients who did not receive immediate anticoagulation, three (13%) experienced recurrent embolism (one each to brain, kidney and leg) within 10 days of initial embolism. There were no early recurrent emboli in patients receiving immediate anticoagulation or patients in the nonembolic or indeterminate category. Five additional patients experienced probable brain or systemic emboli within the 11 days prior to the marker stroke event. Including these patients, 20% (8 of 40) of all NVAF patients who were not immediately anticoagulated experienced recurrent embolism within 11 days of the initial embolus. Early recurrent emboli are common in NVAF patients who experience embolic stroke.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6658950     DOI: 10.1161/01.str.14.5.688

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  28 in total

Review 1.  Management of patients with stroke treated with direct oral anticoagulants.

Authors:  D J Seiffge; A A Polymeris; J Fladt; P A Lyrer; S T Engelter; Gian Marco De Marchis
Journal:  J Neurol       Date:  2018-10-06       Impact factor: 4.849

Review 2.  Anticoagulation Resumption After Stroke from Atrial Fibrillation.

Authors:  Brian Mac Grory; Shane Flood; Matthew Schrag; Maurizio Paciaroni; Shadi Yaghi
Journal:  Curr Atheroscler Rep       Date:  2019-05-20       Impact factor: 5.113

Review 3.  Common causes of cardiac emboli--left ventricular thrombi and atrial fibrillation.

Authors:  J R Stratton
Journal:  West J Med       Date:  1989-08

4.  Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation.

Authors:  Manuel Cappellari; Monica Carletti; Alessandra Danese; Paolo Bovi
Journal:  J Thromb Thrombolysis       Date:  2016-10       Impact factor: 2.300

Review 5.  Atrial fibrillation, stroke and anticoagulation: what is to be done?

Authors:  J M Kitchens; K M Flegel
Journal:  J Gen Intern Med       Date:  1986 Mar-Apr       Impact factor: 5.128

6.  Controversies in the medical management of stroke.

Authors: 
Journal:  West J Med       Date:  1985-01

Review 7.  Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation.

Authors:  David J Seiffge; David J Werring; Maurizio Paciaroni; Jesse Dawson; Steven Warach; Truman J Milling; Stefan T Engelter; Urs Fischer; Bo Norrving
Journal:  Lancet Neurol       Date:  2018-11-08       Impact factor: 44.182

8.  Before M.A.S.T.-I: analysis of the population of a participating center.

Authors:  M R Rottoli; C Foresti; C A Defanti
Journal:  Ital J Neurol Sci       Date:  1993-01

Review 9.  Plasminogen activators and ischemic stroke: conditions for acute delivery.

Authors:  Gregory J del Zoppo
Journal:  Semin Thromb Hemost       Date:  2013-03-28       Impact factor: 4.180

Review 10.  What have drugs to offer the patient with acute stroke?

Authors:  D G Grosset
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.